SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Laboratory Corp of America Holdings – ‘8-K’ for 9/10/20

On:  Thursday, 9/10/20, at 4:14pm ET   ·   For:  9/10/20   ·   Accession #:  920148-20-49   ·   File #:  1-11353

Previous ‘8-K’:  ‘8-K’ on / for 9/1/20   ·   Next:  ‘8-K’ on / for 9/28/20   ·   Latest:  ‘8-K’ on / for 10/27/20

Magnifying glass tilted right emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 9/10/20  Lab Corp of America Holdings      8-K:7,9     9/10/20   13:222K

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     27K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     16K 
 9: R1          Cover                                               HTML     46K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- lh-20200910_htm                     XML     23K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.CAL  XBRL Calculations -- lh-20200910_cal                 XML      7K 
 5: EX-101.DEF  XBRL Definitions -- lh-20200910_def                  XML      9K 
 6: EX-101.LAB  XBRL Labels -- lh-20200910_lab                       XML     67K 
 7: EX-101.PRE  XBRL Presentations -- lh-20200910_pre                XML     33K 
 3: EX-101.SCH  XBRL Schema -- lh-20200910                           XSD     11K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    17K 
13: ZIP         XBRL Zipped Folder -- 0000920148-20-000049-xbrl      Zip     16K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C: 
  lh-20200910  
 i 9/10/2020 i 0000920148 i false00009201482020-09-102020-09-10

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

FORM  i 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 i September 10, 2020
(Date of earliest event reported)
 i LABORATORY CORPORATION OF AMERICA HOLDINGS
(Exact Name of Registrant as Specified in its Charter)
 i Delaware  i 1-11353  i 13-3757370
(State or other jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

 i 358 South Main Street 
 i Burlington, i North Carolina i 27215
(Address of principal executive offices)(Zip Code)
(Registrant’s telephone number including area code)  i 336- i 229-1127
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 i Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Exchange Act.
Title of Each Class   Trading Symbol   Name of exchange on which registered
 i Common Stock , $0.10 par value   i LH     i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).    
                 Emerging growth company  i 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01Regulation FD Disclosure
LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and Franciscan Missionaries of Our Lady Health System (FMOLHS), announced that they entered into a comprehensive laboratory services relationship that will expand services in Louisiana and Mississippi. LabCorp has acquired FMOLHS' clinical ambulatory laboratory business and select assets and will provide reference testing for all FMOLHS facilities and clinics.
Item 9.01
Financial Statements and Exhibits.

ExhibitExhibit Name
Exhibit 99.1




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LABORATORY CORPORATION OF AMERICA HOLDINGS
Registrant

 By:/s/ SANDRA VAN DER VAART
  Sandra van der Vaart
  Executive Vice President, Chief Legal Officer and Corporate Secretary

 i September 10, 2020


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:9/10/20None on these Dates
 List all Filings 
Top
Filing Submission 0000920148-20-000049   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2020 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Oct. 31, 12:01:07.0am ET